Allergy最新文献

筛选
英文 中文
Secretion of Peanut Protein With IgE Crosslinking Capacity in Human Milk. 具有IgE交联能力的花生蛋白在人乳中的分泌。
IF 12.4 1区 医学
Allergy Pub Date : 2025-10-01 DOI: 10.1111/all.70066
Amy D Burris,Nichole Diaz,Jon B Meddings,Bijoya Karmakar,Tarun Keswani,Sarita U Patil,Antti E Seppo,Kirsi M Järvinen
{"title":"Secretion of Peanut Protein With IgE Crosslinking Capacity in Human Milk.","authors":"Amy D Burris,Nichole Diaz,Jon B Meddings,Bijoya Karmakar,Tarun Keswani,Sarita U Patil,Antti E Seppo,Kirsi M Järvinen","doi":"10.1111/all.70066","DOIUrl":"https://doi.org/10.1111/all.70066","url":null,"abstract":"BACKGROUNDHuman milk provides an infant one of the first routes of exposure to dietary antigens. A better understanding of the levels and functional capacity of maternal dietary proteins in human milk (HM) and their impact on infant food allergy (FA) is needed.OBJECTIVETo measure the quantity and biologic activity of maternal dietary proteins in HM and determine factors associated with their presence.METHODSHM samples from mothers of infants with or without FA were collected before and serially after consumption of a meal with prespecified amounts of peanut, egg, and cow's milk protein. Ara h 2 from peanut, egg ovalbumin, and bovine β-lactoglobulin in HM was detected using ELISA. IgE-crosslinking capacity of Ara h 2 was assessed by the basophil activation test (BAT). Maternal intestinal permeability was measured with the lactulose/mannitol test.RESULTSThirty-nine mothers were included and 69% had measurable Ara h 2 in HM. Secretion of food allergens was variable between different mothers and across allergens, but did not correlate with intestinal permeability. Atopic mothers' milk had a higher peak Ara h 2 concentration (median 246 pg/mL, range 2.0-1634) than nonatopic mothers (median 0 pg/mL, range 0-135, p = 0.017). In samples with the most BAT reactivity, there was a significant correlation between BAT reactivity and Ara h 2 level (R = 0.72, p = 2 × 10-8). Multiple monoclonal antibodies directed at different epitopes detected Ara h 2 at similar levels.CONCLUSIONAra h 2 is secreted in HM as intact protein or significant parts of it that are capable of IgE-crosslinking, found in higher levels in atopic mothers. HM levels of peanut lack correlation with other dietary proteins, which suggests antigen specificity of the secretion of dietary protein into HM.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"9 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145203564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracellular Vesicle miRNAs as Biomarkers of Asthma Severity. 细胞外小泡mirna作为哮喘严重程度的生物标志物。
IF 12.4 1区 医学
Allergy Pub Date : 2025-09-30 DOI: 10.1111/all.70079
Chandrashekhar Prasad,Rachel Griffard,Dong Pei,Steven Haworth,Navneet K Dhillon,Mario Castro,Isaac Kirubakaran Sundar
{"title":"Extracellular Vesicle miRNAs as Biomarkers of Asthma Severity.","authors":"Chandrashekhar Prasad,Rachel Griffard,Dong Pei,Steven Haworth,Navneet K Dhillon,Mario Castro,Isaac Kirubakaran Sundar","doi":"10.1111/all.70079","DOIUrl":"https://doi.org/10.1111/all.70079","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":"103 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145189454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper. 药物引起的眼周和眼表疾病:EAACI立场文件。
IF 12.4 1区 医学
Allergy Pub Date : 2025-09-30 DOI: 10.1111/all.70074
Andrea Leonardi,Banu Bozkurt,Diana Silva,Charlotte G Mortz,Christophe Baudouin,Marina Atanaskovic-Markovic,Vibha Sharma,Serge Doan,Shweta Agarwal,Daniel Pérez-Formigo,Maria Joao Vasconcelos,Francoise-Brignole Baudouin,Gonzalo Chorzepa,Jean-Luc Fauquert,Virginia Calder,Pascal Demoly,Luis Delgado
{"title":"Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper.","authors":"Andrea Leonardi,Banu Bozkurt,Diana Silva,Charlotte G Mortz,Christophe Baudouin,Marina Atanaskovic-Markovic,Vibha Sharma,Serge Doan,Shweta Agarwal,Daniel Pérez-Formigo,Maria Joao Vasconcelos,Francoise-Brignole Baudouin,Gonzalo Chorzepa,Jean-Luc Fauquert,Virginia Calder,Pascal Demoly,Luis Delgado","doi":"10.1111/all.70074","DOIUrl":"https://doi.org/10.1111/all.70074","url":null,"abstract":"Various systemic and topical medications can induce ocular and periocular cutaneous adverse effects (AEs), ranging from mild to severe. These AEs may lead to ocular surface (OS) damage and, in some cases, life-threatening complications. Drug-induced ocular adverse reactions are generally classified into two primary categories: toxic reactions and/or allergic hypersensitivity reactions, which can be IgE or non-IgE-mediated. Systemic antibiotics, antivirals, and anticonvulsants can trigger adverse reactions that may involve the OS. Drugs like antihistamines, beta-blockers, antipsychotics, antidepressants, and isotretinoin are linked to dry eye disease. Topical treatments-including antibiotics, antiglaucoma medications, preservatives, contact lens solutions, and cosmetics-may elicit allergic or toxic ocular diseases. Recent evidence implicates ocular surface AEs in patients undergoing biological treatments for oncological diseases and atopic dermatitis. Epidermal growth factor receptor inhibitors, used in the treatment of several cancers, have been associated with conjunctivitis, meibomitis, dry eye, periocular skin changes, and trichomegaly. Similarly, dupilumab, the first biologic approved for treating moderate-to-severe atopic dermatitis, has also been linked to OS disease with blepharoconjunctivitis. This position paper provides a comprehensive overview of the clinical presentations, diagnostic approaches, and treatment strategies for drug-induced ocular AEs, integrating the latest literature and clinical guidelines.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"75 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145189184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age-Related Increase in Anaphylaxis Severity Is Associated With Enhanced Sensitivity to Allergic Mediators. 与年龄相关的过敏反应严重程度增加与对过敏介质的敏感性增强有关。
IF 12.4 1区 医学
Allergy Pub Date : 2025-09-29 DOI: 10.1111/all.70082
Daniel Brigger,Melanie Steinmann,Nadine Roos,Pascal Guntern,Oliver M Würgler,Lukas Michaja Balsiger,Alexander Eggel
{"title":"Age-Related Increase in Anaphylaxis Severity Is Associated With Enhanced Sensitivity to Allergic Mediators.","authors":"Daniel Brigger,Melanie Steinmann,Nadine Roos,Pascal Guntern,Oliver M Würgler,Lukas Michaja Balsiger,Alexander Eggel","doi":"10.1111/all.70082","DOIUrl":"https://doi.org/10.1111/all.70082","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":"20 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small Intestinal Dilation Is Associated With Severe Abdominal Symptoms of Food-Protein-Induced Enterocolitis Syndrome in Adults. 成人食物蛋白诱导的小肠结肠炎综合征的严重腹部症状与小肠扩张相关
IF 12.4 1区 医学
Allergy Pub Date : 2025-09-29 DOI: 10.1111/all.70081
Sho Watanabe,Ayako Sato,Keitaro Shibuya,Rina Kusuda,Tsunehito Yauchi,Tatsuki Fukuie,Kiwako Yamamoto-Hanada,Yukihiro Ohya,Ichiro Nomura
{"title":"Small Intestinal Dilation Is Associated With Severe Abdominal Symptoms of Food-Protein-Induced Enterocolitis Syndrome in Adults.","authors":"Sho Watanabe,Ayako Sato,Keitaro Shibuya,Rina Kusuda,Tsunehito Yauchi,Tatsuki Fukuie,Kiwako Yamamoto-Hanada,Yukihiro Ohya,Ichiro Nomura","doi":"10.1111/all.70081","DOIUrl":"https://doi.org/10.1111/all.70081","url":null,"abstract":"BACKGROUNDFood-Protein-Induced Enterocolitis Syndrome (FPIES) is a non-IgE-mediated food allergy that causes gastrointestinal symptoms, though its anatomical origin and pathogenesis remain unclear. Abdominal distention is common in adult FPIES, but symptoms vary among patients. This study aimed to establish objective criteria for assessing abdominal distention and to clarify the pathophysiology and anatomical origin of FPIES.METHODSThis study targeted 26 adult FPIES patients. Abdominal distention was broken down into eight factors, and an evaluation algorithm was developed based on items with high positivity rates. Clinical characteristics, blood, and imaging analyses were performed before and after OFC (oral food challenge) to investigate the pathophysiology.RESULTSAmong 14 adult FPIES patients who underwent OFC, seven showed positive results. The latency period was 1.5 h, with the most frequent symptoms being abdominal distention (100%), abdominal pain, and nausea (71.4%). All patients received treatment with intravenous extracellular fluid infusion and ondansetron, which resulted in reduced symptom duration. In an evaluation of blood test data, there were no specific serological markers of FPIES, except in the severe case. Image analysis with computed tomography revealed significant dilation and edema of the small intestine during the FPIES event, suggesting that dilation of the small intestine is associated with adult FPIES.CONCLUSIONThese results are expected to aid in the early and appropriate diagnosis of FPIES based on medical interviews, blood test data, and imaging findings when adult patients present to medical institutions with severe acute gastroenteritis symptoms.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"100 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining Atopic Dermatitis Through the One Health Concept Lens. 通过一个健康概念透镜检查特应性皮炎。
IF 12.4 1区 医学
Allergy Pub Date : 2025-09-27 DOI: 10.1111/all.70080
Dijana Minić-Pantić,Bernadette Abela,Jenni Lehtimäki,Alexander Zink,Erika Jensen-Jarolim,Antonia Fettelschoss-Gabriel,Claudia Traidl-Hoffmann,Johannes Ring,Peter Schmid-Grendelmeir,Pascal Prélaud,Alain Taïeb
{"title":"Examining Atopic Dermatitis Through the One Health Concept Lens.","authors":"Dijana Minić-Pantić,Bernadette Abela,Jenni Lehtimäki,Alexander Zink,Erika Jensen-Jarolim,Antonia Fettelschoss-Gabriel,Claudia Traidl-Hoffmann,Johannes Ring,Peter Schmid-Grendelmeir,Pascal Prélaud,Alain Taïeb","doi":"10.1111/all.70080","DOIUrl":"https://doi.org/10.1111/all.70080","url":null,"abstract":"This paper explores the application of the One Health framework to atopic dermatitis (AD), a complex, chronic skin disease, emphasizing interdisciplinary approaches to prevention and management. One Health integrates human, animal, environmental, and plant health, addressing challenges such as antimicrobial resistance, infectious diseases, and neglected tropical diseases (NTDs). In the context of AD, One Health principles are applied to explore etiological factors like urbanization, climate change, biodiversity loss, and environmental pollution. Key findings include the interplay between lifestyle and environmental exposures, as evidenced by studies on human-dog microbiota sharing, which reveal that rural environments confer protective effects against allergic conditions for both species. Historical observations of the \"old farm effect\" highlight the protective role of traditional rural living, including raw milk consumption, in preventing atopic diseases. However, modern urbanization and industrial farming have eroded these benefits. Climate change intensifies AD symptoms through extreme weather, proliferation of more and higher allergenic pollen, likely also of house dust mites, allergen proliferation, and pollution. Rising CO2 levels exacerbate pollen allergenicity, prolong pollen seasons, and amplify allergic responses. The skin's microbiome and immune barrier are sensitive to pollutants like black carbon and traffic-related emissions, further influencing AD prevalence and severity. Innovative approaches to prevention, such as veterinary vaccination strategies targeting allergens or immunopathological key cytokines, illustrate cross-species solutions. Web data mining demonstrates potential for analyzing public interest and seasonal trends in AD, correlating search data with real-time monitored environmental factors and highlighting gaps in awareness and access to modern treatments. This integrative One Health lens provides a framework for reimagining AD prevention and management, emphasizing a return to environmental and lifestyle diversity, climate action, and leveraging digital and biomedical tools for personalized, sustainable care.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"62 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145153528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tezepelumab Targeting Thymic Stromal Lymphopoietin Enhances Steroid Sensitivity in Patients With Severe Asthma. Tezepelumab靶向胸腺基质淋巴生成素增强严重哮喘患者的类固醇敏感性
IF 12.4 1区 医学
Allergy Pub Date : 2025-09-27 DOI: 10.1111/all.70083
Keita Hirai,Sekiko Uehara,Toshihiro Shirai,Taisuke Akamatsu,Kunihiko Itoh
{"title":"Tezepelumab Targeting Thymic Stromal Lymphopoietin Enhances Steroid Sensitivity in Patients With Severe Asthma.","authors":"Keita Hirai,Sekiko Uehara,Toshihiro Shirai,Taisuke Akamatsu,Kunihiko Itoh","doi":"10.1111/all.70083","DOIUrl":"https://doi.org/10.1111/all.70083","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":"42 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145153531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report. 变应性鼻炎治疗对患者满意度的比较:MASK-air和EAACI方法学委员会报告。
IF 12.4 1区 医学
Allergy Pub Date : 2025-09-26 DOI: 10.1111/all.70055
Bernardo Sousa-Pinto,Rafael José Vieira,Antonio Bognanni,Matteo Martini,Michal Ordak,Giovanni Paoletti,Sara Gil-Mata,Rita Amaral,Anna Bedbrook,Patrizia Bonadonna,Luisa Brussino,G Walter Canonica,João Coutinho-Almeida,Álvaro A Cruz,Wienczyslawa Czarlewski,Mark Dykewicz,Mattia Giovannini,Bilun Gemicioglu,Juan Carlos Ivancevich,Ludger Klimek,Violeta Kvedariene,Desiree E Larenas-Linnemann,Manuel Marques-Cruz,André Moreira,Marek Niedoszytko,Ana Margarida Pereira,Nikolaos G Papadopoulos,Nhan Pham-Thi,Frederico S Regateiro,Sanna K Toppila-Salmi,Boleslaw Samolinski,Joaquin Sastre,Luís Taborda-Barata,Tuuli Thomander,Ilgım Vardaloğlu Koyuncu,Arunas Valiulis,Leticia de Las Vecillas,Maria Teresa Ventura,Jolanta Walusiak-Skorupa,Yi-Kui Xiang,Oliver Pfaar,João A Fonseca,Torsten Zuberbier,Holger J Schünemann,Danilo di Bona,Jean Bousquet
{"title":"Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report.","authors":"Bernardo Sousa-Pinto,Rafael José Vieira,Antonio Bognanni,Matteo Martini,Michal Ordak,Giovanni Paoletti,Sara Gil-Mata,Rita Amaral,Anna Bedbrook,Patrizia Bonadonna,Luisa Brussino,G Walter Canonica,João Coutinho-Almeida,Álvaro A Cruz,Wienczyslawa Czarlewski,Mark Dykewicz,Mattia Giovannini,Bilun Gemicioglu,Juan Carlos Ivancevich,Ludger Klimek,Violeta Kvedariene,Desiree E Larenas-Linnemann,Manuel Marques-Cruz,André Moreira,Marek Niedoszytko,Ana Margarida Pereira,Nikolaos G Papadopoulos,Nhan Pham-Thi,Frederico S Regateiro,Sanna K Toppila-Salmi,Boleslaw Samolinski,Joaquin Sastre,Luís Taborda-Barata,Tuuli Thomander,Ilgım Vardaloğlu Koyuncu,Arunas Valiulis,Leticia de Las Vecillas,Maria Teresa Ventura,Jolanta Walusiak-Skorupa,Yi-Kui Xiang,Oliver Pfaar,João A Fonseca,Torsten Zuberbier,Holger J Schünemann,Danilo di Bona,Jean Bousquet","doi":"10.1111/all.70055","DOIUrl":"https://doi.org/10.1111/all.70055","url":null,"abstract":"INTRODUCTIONSatisfaction with treatments may affect medication adherence and use patterns, including the use of co-medication. We aimed to compare different medications for allergic rhinitis (AR) on (i) patients' satisfaction and (ii) co-medication use frequency.METHODSWe assessed data from the mHealth app MASK-air. We evaluated days on which users with self-reported AR had used-alone or in co-medication-intranasal corticosteroids (INCS), intranasal antihistamines (INAH), fixed combinations of INAH+INCS, or oral antihistamines (OAH). We built multivariable regression models to compare these different AR medication classes (as well as individual medications) on their (i) treatment satisfaction levels (measured using a specific daily visual analogue scale ['VAS satisfaction']) and (ii) odds of being used in co-medication.RESULTSWe assessed 28,177 days reported by 1691 MASK-air users. For all medication classes, co-medication usage was associated with lower treatment satisfaction. When used in monotherapy, OAH were associated with lower VAS satisfaction than INCS (-1.7 points; 95% CI = -2.7; -0.7) or INAH+INCS (-2.1 points; 95% CI = -3.5; -0.7). INCS displayed higher odds of being used in co-medication than OAH (OR = 1.3; 95% CI = 1.0; 1.6) or INAH+INCS (OR = 1.3; 95% CI = 0.8; 1.8). When comparing individual intranasal medications, fluticasone furoate and fluticasone propionate tended to be more frequently used in co-medication. Among individual OAH, desloratadine and rupatadine were associated with higher satisfaction, while fexofenadine was more frequently used in co-medication.CONCLUSIONUsing patient-reported data, we evaluated different medication classes and treatments in terms of satisfaction and co-medication frequency. These results provide key insights into the acceptability of AR treatments and will contribute to future treatment guidelines.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"18 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria. 重度哮喘和慢性荨麻疹患者自我给予生物治疗的回顾性分析。
IF 12.4 1区 医学
Allergy Pub Date : 2025-09-26 DOI: 10.1111/all.70078
Hazal Kayıkçı,Ebru Damadoglu,Melek Cihanbeylerden,Çise Tüccar,Ayşegül Pehlivanlar Ustaoğlu,Gül Karakaya,Ali Fuat Kalyoncu
{"title":"Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria.","authors":"Hazal Kayıkçı,Ebru Damadoglu,Melek Cihanbeylerden,Çise Tüccar,Ayşegül Pehlivanlar Ustaoğlu,Gül Karakaya,Ali Fuat Kalyoncu","doi":"10.1111/all.70078","DOIUrl":"https://doi.org/10.1111/all.70078","url":null,"abstract":"","PeriodicalId":122,"journal":{"name":"Allergy","volume":"89 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-Life Clinical Experience With SQ Grass, Tree, Ragweed, and House Dust Mite Sublingual Immunotherapy Tablets: A Review of Evidence From Non-Interventional Studies. SQ草、树、豚草和尘螨舌下免疫治疗片的实际临床经验:来自非介入性研究的证据综述。
IF 12.4 1区 医学
Allergy Pub Date : 2025-09-26 DOI: 10.1111/all.70039
Oliver Pfaar,Christer Janson,Andreas Horn,André C Knulst,Pascal Demoly
{"title":"Real-Life Clinical Experience With SQ Grass, Tree, Ragweed, and House Dust Mite Sublingual Immunotherapy Tablets: A Review of Evidence From Non-Interventional Studies.","authors":"Oliver Pfaar,Christer Janson,Andreas Horn,André C Knulst,Pascal Demoly","doi":"10.1111/all.70039","DOIUrl":"https://doi.org/10.1111/all.70039","url":null,"abstract":"This review evaluates data from > 12,000 children, adolescents and adults (≥ 4 years) in non-interventional studies to assess the real-life effectiveness and safety of SQ sublingual immunotherapy (SLIT)-tablets for allergic rhinitis (AR). Non-interventional studies of SQ grass, tree, ragweed, and house dust mite (HDM) SLIT tablets were identified from PubMed (1 January 2006 to 11 February 2025) and supplemented by manual searches. Effectiveness was captured as patient-reported change in AR symptoms; AR and/or asthma medication use, safety and treatment satisfaction were also evaluated. In total, 12,136 participants were enrolled across 22 SQ SLIT tablet studies (grass: n = 6744; HDM: n = 4323; tree: n = 1069; ragweed: n = 102). Across studies, a high proportion of participants reported improvements from baseline or the previous season across nasal (up to 87%), ocular (up to 81%), and bronchial symptoms (up to 78%) with SQ SLIT tablets. Compared to baseline, a lower proportion of patients reported use of symptom-relieving medication, consistent across key drug classes including oral antihistamine, intranasal corticosteroids, short-acting beta-agonist, and inhaled corticosteroids. Discontinuations due to adverse events were low (0%-14.5%). Among studies reporting treatment satisfaction, 73%-96% of participants were found to be 'satisfied' or 'very satisfied' with this treatment. SQ SLIT tablets showed consistent effectiveness for AR, were well-tolerated, and were associated with a high degree of patient satisfaction. These real-life data from clinical practice are a valuable and important source of complementary evidence to the well established efficacy and safety from randomised clinical trials.","PeriodicalId":122,"journal":{"name":"Allergy","volume":"77 1","pages":""},"PeriodicalIF":12.4,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145153545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信